Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma
10.1158/0008-5472.CAN-08-1329
Saved in:
Main Authors: | Mori, S., Rempel, R.E., Chang, J.T., Yao, G., Lagoo, A.S., Potti, A., Bild, A., Nevins, J.R. |
---|---|
Other Authors: | NATIONAL UNIVERSITY MEDICAL INSTITUTES |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/109729 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The Contribution of MYC and PLK1 Expression to Proliferative Capacity in Diffuse Large B-Cell Lymphoma
by: Ming Liang Oon, et al.
Published: (2020) -
Plasma Factors for the Differentiation of Hodgkin's Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission.
by: Zeng, Qun, et al.
Published: (2023) -
Anterior panhypopituitarism in diffuse large B-cell stage IV lymphoma
by: Valeros, K.A., et al.
Published: (2016) -
Utilization of genomic signatures to identify phenotype-specific drugs
by: Mori, S., et al.
Published: (2014) -
JNK1 and JNK2 play redundant functions in Myc-induced B cell lymphoma formation
by: Anbalagan, M., et al.
Published: (2014)